Selective loss of the transforming growth factor-β apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells

Sarit Larisch-Bloch, David Danielpour, Nanette S. Roche, Rona Lotan, Andrew Y. Hsing, Hedviga Kerner, Taleb Hajouj, Robert J. Lechleider, Anita B. Roberts

Research output: Contribution to journalArticlepeer-review

Abstract

Retroviral insertional mutagenesis was used to select mutant NRP-154 rat prostate carcinoma cells resistant to transforming growth factor (TGF)-β- induced cell death. Similar to the parental cells, a mutant clone, M-NRP1, expressed TGF-β receptors and was still responsive to induction both of direct target genes by TGF-β and of apoptosis by staurosporine or okadaic acid. In contrast, indicators of cell growth, strongly suppressed by TGF-β in the parental cells, were unaffected in M-NRP1 cells. M-NRP1 cells overexpress the antiapoptotic protein, Bcl-xL, and show dysregulated expression and localization of a protein related to a novel human septin, ARTS (designation of apoptotic response to TGF-β signals), cloned by homology to an exonic sequence flanked by the viral long terminal repeats in M-NRP1 cells and shown to make cells competent to undergo apoptosis in response to TGF-β. We propose that ARTS might operate within the same apoptotic pathway as Bcl-xL and that M-NRP1 cells could serve as a useful model for characterization of this pathway.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalCell Growth and Differentiation
Volume11
Issue number1
StatePublished - Jan 2000
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Selective loss of the transforming growth factor-β apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells'. Together they form a unique fingerprint.

Cite this